ADAGE CAPITAL PARTNERS GP, L.L.C. - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 93 filers reported holding XENON PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ADAGE CAPITAL PARTNERS GP, L.L.C. ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$18,788,000
-27.2%
550,000
-17.9%
0.04%
-23.2%
Q2 2023$25,795,000
-3.9%
670,000
-10.7%
0.06%
-6.7%
Q1 2023$26,842,500
-6.1%
750,000
+3.4%
0.06%
-11.8%
Q4 2022$28,586,750
+17.3%
725,000
+7.4%
0.07%
+13.3%
Q3 2022$24,368,000
+27.1%
675,000
+7.1%
0.06%
+36.4%
Q2 2022$19,165,000
-3.6%
630,000
-3.1%
0.04%
+15.8%
Q1 2022$19,871,000
-4.4%
650,000
-2.3%
0.04%
+2.7%
Q4 2021$20,775,000
+15.7%
665,000
-43.4%
0.04%
+5.7%
Q3 2021$17,954,000
-36.8%
1,175,000
-23.0%
0.04%
-37.5%
Q2 2021$28,396,000
-37.8%
1,525,000
-40.2%
0.06%
-39.8%
Q1 2021$45,645,000
+21.1%
2,550,000
+4.1%
0.09%
+13.4%
Q4 2020$37,681,000
+38.9%
2,450,0000.0%0.08%
+20.6%
Q3 2020$27,122,000
+6.8%
2,450,000
+21.0%
0.07%
+4.6%
Q2 2020$25,394,000
+10.6%
2,025,0000.0%0.06%
-5.8%
Q1 2020$22,964,000
-9.0%
2,025,000
+5.2%
0.07%
+11.3%
Q4 2019$25,237,000
+115.5%
1,925,000
+48.1%
0.06%
+113.8%
Q3 2019$11,713,000
-8.6%
1,300,0000.0%0.03%
-9.4%
Q2 2019$12,818,000
-3.0%
1,300,0000.0%0.03%
-3.0%
Q1 2019$13,208,000
+61.0%
1,300,0000.0%0.03%
+43.5%
Q4 2018$8,203,000
-48.2%
1,300,000
+8.3%
0.02%
-34.3%
Q3 2018$15,840,000
+115.2%
1,200,000
+50.0%
0.04%
+105.9%
Q2 2018$7,360,000800,0000.02%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 850,000$15,215,0003.58%
ACUTA CAPITAL PARTNERS, LLC 412,500$7,384,0002.66%
BVF INC/IL 3,481,778$62,324,0002.34%
Soleus Capital Management, L.P. 708,117$12,675,0002.28%
COMMODORE CAPITAL LP 301,392$5,395,0002.15%
DAFNA Capital Management LLC 406,535$7,277,0001.73%
Parkman Healthcare Partners LLC 374,395$6,702,0001.56%
Avoro Capital Advisors LLC 3,650,000$65,335,0001.13%
KNOTT DAVID M 144,101$2,579,0001.10%
Orbimed Advisors 2,497,917$44,713,0000.42%
View complete list of XENON PHARMACEUTICALS INC shareholders